Safety Tolerability Pharmacokinetics Pharmacodynamics and Initial Efficacy of ASK8007 in Comparison With Placebo in Patients With Active Rheumatoid Arthritis - a Randomized Double Blind Placebo-Controlled Combined Single Dose Escalation and Multiple Dose Study

Trial Profile

Safety Tolerability Pharmacokinetics Pharmacodynamics and Initial Efficacy of ASK8007 in Comparison With Placebo in Patients With Active Rheumatoid Arthritis - a Randomized Double Blind Placebo-Controlled Combined Single Dose Escalation and Multiple Dose Study

Completed
Phase of Trial: Phase I/II

Latest Information Update: 12 Jun 2013

At a glance

  • Drugs ASK 8007 (Primary)
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 14 Sep 2011 Results published in the Annals of the Rheumatic Diseases.
    • 14 Apr 2009 Planned number of patients changed from 48 to 54, additional trial location identified as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top